We develop and offer lab based challenge models of the most economically important infections.  We've a fantastic track record with sea lice, and we've now expanded to take on AGD (amoebic gill disease).  We'll add more as the industry requires:

  • Sea lice in life challenge model
  • Sea lice copepodid drug screening
  • Drug-resistant and drug-naive strains of sea lice
  • Sea lice drug resistance testing and monitoring service
  • AGD in life challenge model
  • Bacterial infections
  • Saprolegnia
  • Drug development and testing
  • Vaccine development and testing
  • Functional feed testing
  • Feed development and testing against infection
  • Genetic resistance of salmon to infection